Unicycive Therapeutics Files 8-K Report
Ticker: UNCY · Form: 8-K · Filed: May 21, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
Unicycive Therapeutics filed an 8-K, likely containing important company updates.
AI Summary
On May 21, 2025, Unicycive Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Unicycive Therapeutics is making a regulatory disclosure, which could contain important updates for investors regarding company events or financial status.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material information that would indicate a high-risk event.
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- May 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40582 (filing_id) — SEC File Number
- 81-3638692 (ein) — IRS Employer Identification No.
- 4300 El Camino Real, Suite 210 (address) — Principal executive offices
- Los Altos, CA 94022 (address) — Principal executive offices
- (650) 351-4495 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by Unicycive Therapeutics, Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported; it only indicates that this item is being addressed in the filing.
What "Financial Statements and Exhibits" are included in this 8-K filing?
The excerpt states that "Financial Statements and Exhibits" are part of the filing, but does not list the specific documents included.
What is the principal executive office address for Unicycive Therapeutics, Inc.?
The principal executive offices are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated May 21, 2025.
What is the SEC File Number for Unicycive Therapeutics, Inc.?
The SEC File Number for Unicycive Therapeutics, Inc. is 001-40582.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).